References
Kumagai, S. et al. Nat. Immunol. 21, 1346–1358 (2020).
Ahmadzadeh, M. et al. Blood 114, 1537–1544 (2009).
Yokosuka, T. et al. J. Exp. Med. 209, 1201–1217 (2012).
Hui, E. et al. Science 355, 1428–1433 (2017).
Kansy, B. A. et al. Cancer Res. 77, 6353–6364 (2017).
Gros, A. et al. J. Clin. Invest. 124, 2246–2259 (2014).
Daud, A. I. et al. J. Clin. Invest. 126, 3447–3452 (2016).
Thommen, D. S. et al. Nat. Med. 24, 994–1004 (2018).
Lowther, D. E. et al. JCI Insight 1, e85935 (2016).
Kamada, T. et al. Proc. Natl Acad. Sci. USA 116, 9999–10008 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Zhang, K., Jiang, S. A new predictive biomarker enables more accurate PD-1 blockade therapy. Cell Mol Immunol 18, 1624–1625 (2021). https://doi.org/10.1038/s41423-021-00645-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-021-00645-4
- Springer Nature Limited